Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) traded up 1.6% on Monday . The company traded as high as $4.54 and last traded at $4.54. 201 shares changed hands during trading, a decline of 85% from the average session volume of 1,346 shares. The stock had previously closed at $4.47.
Mayne Pharma Group Price Performance
The firm’s fifty day moving average price is $4.31 and its 200-day moving average price is $3.62.
Mayne Pharma Group Company Profile
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
Featured Stories
- Five stocks we like better than Mayne Pharma Group
- How to Capture the Benefits of Dividend Increases
- High-Yield Texas Instruments Could Hit New Highs Soon
- Bank Stocks – Best Bank Stocks to Invest In
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What is the S&P 500 and How It is Distinct from Other Indexes
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.